New drug tested to help control painful arthritis symptoms
NCT ID NCT01143337
Summary
This study tested whether adding an experimental drug called MP-435 to standard methotrexate treatment could better control rheumatoid arthritis symptoms. It involved 112 adults with active arthritis who weren't getting enough relief from methotrexate alone. Participants received either MP-435 or a placebo pill for 12 weeks while continuing their regular methotrexate, to see if the combination reduced joint pain and swelling more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Osaka, Japan
Conditions
Explore the condition pages connected to this study.